Compare BK & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BK | BSX |
|---|---|---|
| Founded | 1784 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9B | 93.4B |
| IPO Year | 2013 | 2010 |
| Metric | BK | BSX |
|---|---|---|
| Price | $137.43 | $47.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 22 |
| Target Price | ★ $134.42 | $93.18 |
| AVG Volume (30 Days) | 3.0M | ★ 21.0M |
| Earning Date | 04-16-2026 | 04-22-2026 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | 27.59 | ★ 55.20 |
| EPS | ★ 2.24 | 0.90 |
| Revenue | ★ $20,080,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $9.23 | $11.85 |
| Revenue Next Year | $4.53 | $10.16 |
| P/E Ratio | $61.23 | ★ $53.70 |
| Revenue Growth | 7.85 | ★ 12.49 |
| 52 Week Low | $88.19 | $47.17 |
| 52 Week High | $139.15 | $109.50 |
| Indicator | BK | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 30.55 |
| Support Level | $130.53 | $47.17 |
| Resistance Level | $139.15 | $58.35 |
| Average True Range (ATR) | 2.69 | 1.46 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 82.69 | 8.19 |
Bank of New York Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors, delivering investment management and services in 35 countries and more than 100 markets. BNY is the largest global custody bank in the world, with $59.3 trillion in under custody or administration (as of December 2025), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY's asset-management division manages about $2.2 trillion in assets.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.